Laden…
Synapedia is an independent knowledge project about psychoactive substances and harm reduction. If the platform helps you learn something new, you can support its development.
Every bit helps keep the project alive.
Evidence-based risk assessment and known adverse effects
Risk Classification: Unclassified
The risk profile of Cannabis has not been fully characterised. Insufficient scientific data is available to draw definitive conclusions.
Neurotoxicity
possible
Aggregated from 3 verified experience reports. Community data reflects reported subjective experiences, not clinical outcomes.
The following substances carry an elevated risk of adverse interactions with Cannabis. This list is not exhaustive.
For a full interaction overview, see the Interactions page.
Route of administration significantly influences the risk profile. Intravenous and inhalation routes carry substantially higher risks than oral administration. Commonly reported routes for Cannabis:
general
Vaporizer bevorzugen: Vaporisieren statt Rauchen reduziert Atemwegsbelastung erheblich und ermoeglicht praezisere Dosierung.
general
Edibles extrem vorsichtig dosieren: Beginne mit 2,5-5 mg THC. Warte mindestens 2 Stunden auf die Wirkung bevor du nachdosierst - Edibles wirken stark verzoegert.
general
Niedrig-THC/Hoch-CBD Produkte fuer Einsteieger: CBD mildert die psychoaktive THC-Wirkung und reduziert Angst- und Paranoia-Risiko.
general
Nicht kombinieren mit Alkohol: verstaerkt Beeintraechtigung und Uebelkeit erheblich.
general
Nicht fahren oder arbeiten: Cannabis beeintraechtigt Reaktionsvermoeegen und Konzentration fuer mehrere Stunden.
general
Keine regelmaessige Anwendung unter 25 Jahren - Einfluss auf Hirnentwicklung.
Based on 3 verified experience reports.
Disclaimer: This information is provided for educational purposes only and does not constitute medical advice. If you have concerns about substance use, please consult a qualified healthcare professional or contact a local drug support service.